Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 19 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Faselis, Charles [Clear All Filters]
Benefits from treatment and control of patients with resistant hypertension..
Int J Hypertens. 2011, 318549.
(2010). Carotid baroreceptor stimulation for the treatment of resistant hypertension..
Int J Hypertens. 2011, 964394.
(2011). Determinants of pulse wave velocity index and potential implementations..
J Clin Hypertens (Greenwich).
(2019). Exercise capacity and all-cause mortality in prehypertensive men..
Am J Hypertens. 22(7), 735-41.
(2009). Exercise capacity and mortality in hypertensive men with and without additional risk factors..
Hypertension. 53(3), 494-9.
(2009). Exercise capacity and mortality in older men: a 20-year follow-up study..
Circulation. 122(8), 790-7.
(2010). Gender differences in hypertension: myths and reality..
Curr Hypertens Rep. 15(4), 321-30.
(2013). A graded association of exercise capacity and all-cause mortality in males with high-normal blood pressure..
Blood Press. 18(5), 261-7.
(2009).
(2013).
Left ventricular hypertrophy as a determinant of renal outcome in patients with high cardiovascular risk..
J Hypertens. 28(11), 2299-308.
(2010). Left ventricular hypertrophy in athletes and hypertensive patients..
J Clin Hypertens (Greenwich). 19(4), 413-417.
(2017). Non-interventional management of resistant hypertension..
World J Cardiol. 6(10), 1080-90.
(2014). Novel Drugs for Hypertension and Heart Failure: Struggling for a Place Under the Sun..
Curr Pharm Des. 23(10), 1540-1550.
(2017). Renal sympathetic denervation and systemic hypertension..
Am J Cardiol. 105(4), 570-6.
(2010). Renal sympathetic denervation in hypertension..
Curr Opin Nephrol Hypertens. 20(6), 647-53.
(2011). SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature..
Curr Pharm Des. 23(10), 1510-1521.
(2017). Statin and exercise prescription - Authors' reply..
Lancet. 381(9878), 1622-3.
(2013). Statin therapy, fitness, and mortality risk in middle-aged hypertensive male veterans..
Am J Hypertens. 27(3), 422-30.
(2014). Time in Therapeutic Range, as a Determinant of All-Cause Mortality in Patients With Hypertension..
J Am Heart Assoc. 6(11),
(2017).